Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of Remimazolam for Cataract Surgery
Sponsor: Fred E, Shapiro
Summary
The goal of this clinical trial is to learn if the use of the sedative remimazolam improves the safety of patients having cataract surgery by decreasing the number of sedation-related complications during and after surgery, and shortening post-surgical cognitive recovery time.
Official title: Remimazolam for Sedation in Cataract Surgery, A Phase IV, On-label, Blinded Study
Key Details
Gender
All
Age Range
55 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-02-15
Completion Date
2027-12-01
Last Updated
2026-01-08
Healthy Volunteers
Yes
Conditions
Interventions
Arm 1 Cataract Surgery performed with remimazolam as sedative
Sedation will be remimazolam in one eye and the standard of care in the other eye.
Arm 2 Cataract Surgery performed with standard of care sedative
Standard of care sedative will be used during surgery.
Locations (1)
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States